<DOC>
	<DOC>NCT00784433</DOC>
	<brief_summary>Moderate alcohol may be beneficial for diabetics</brief_summary>
	<brief_title>The CArdiovasCulAr Diabetes &amp; Ethanol (CASCADE) Trial</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>Established diagnosis of type 2 diabetes Male or female alcohol abstainers (not more than 1 drink/week) Age between 4075 yrs Clinically stable, with no history of stroke or myocardial infarction or major surgery within the previous 3 months The use of RI or shortacting analog insulin/ pump therapy. Patients on 12 injections per day of NPH or longacting analogs will be eligible for inclusion Triglycerides &gt; 500 mg/dL HbA1c&lt;7 or &gt; 10% Serum creatinine &gt; 2 mg/dl Liver dysfunction (greater than 2fold elevation of ALT or and 3fold elevation of AST) Evidence of severe diabetes complications (such as proliferative retinopathy or overt nephropathy) Autonomic neuropathy manifested as postural hypotension or hypoglycemia unawareness Patients with chronic hepatitis (C,B) Use of drugs that might significantly interact with alcohol such as sedatives, antihistamines, and anticoagulants Presence of active cancer, or chemotherapy within the past 3 years Major illness that may require hospitalization A high potential of addictive behavior based on physician's assessment or personal or family history of addiction, alcoholism, or alcohol abuse Pregnant or lactating woman Participation in another trial with active intervention</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>alcohol diabetes CVD</keyword>
</DOC>